Literature DB >> 27579390

Castleman Disease Presenting as Renal Hilar Mass.

Mohammad Hadi Radfar1, Hamid Pakmanesh2, Peyman Torbati3.   

Abstract

BACKGROUND: We report a case of unicentric Castleman disease, a rare type of benign proliferation of lymphoid tissue. We present an uncommon disease that was managed effectively using laparoscopy. CASE
PRESENTATION: A 32-year-old woman presented with left-sided flank pain. A large retroperitoneal mass was detected in the left renal hilum close to the renal vessels. Laparoscopic removal of the mass was effectively performed. The pathologic examination was in favor of a rare type of benign proliferation of lymphoid tissue compatible with Castleman disease. The patient was cured with no evidence of recurrence in 1-year follow-up.
CONCLUSION: Transperitoneal laparoscopic approach is feasible and effective in the management of this disease and is curative.

Entities:  

Year:  2015        PMID: 27579390      PMCID: PMC4996621          DOI: 10.1089/cren.2015.0015

Source DB:  PubMed          Journal:  J Endourol Case Rep        ISSN: 2379-9889


Introduction

Castleman disease is a rare type of benign proliferation of lymphoid tissue. Other nominations of this disease are giant or angiofollicular lymph node hyperplasia, lymphoid hamartoma, and angiofollicular lymph node hyperplasia. It is an uncommon lymphoproliferative disorder characterized by noncancerous growths (tumors) that may develop in the lymph node tissue at a single site or throughout the body.[1] Unicentric Castleman disease involves tissue growth at only a single site. There are few or no symptoms other than those directly associated with the enlargement of the lymph node. Mass resection is almost always curative and no complementary treatment is recommended.[2] The etiology is unknown and hyperproliferation of some B cells that often produce IL-6 is observed.[1] In contrast, the multicentric disease is linked to HHV-8 and is associated with systemic presentations such as B-symptoms. No standard definitive treatment has been established for the multicentric disease.[2] Involvement of the kidney is extremely rare in this disease.[3] Williams and colleagues first reported laparoscopic removal of intraabdominal Castleman disease for the treatment of a subhepatic mass.[4] This disease only rarely involves genitourinary tract.[5] We report a case of unicentric Castleman disease, which presented as a retroperitoneal mass adjacent to the renal hilum.

Case Presentation

A 32-year-old woman presented with dull left flank pain. Physical examination was normal. Abdominal ultrasonography revealed a solid mass with a diameter of 7 cm in the left renal hilum. Abdominal CT scan showed a single well-defined homogeneously enhanced mass close to the left renal pedicle with no calcification or necrosis (Fig. 1A, B). Laboratory data including catecholamine metabolites were in normal range. Chest and abdominopelvic CT scans were normal otherwise. The mass was resected completely laparoscopically using the transperitoneal approach. Although the mass was close to the renal vessels, there were no significant adhesions to the pelvis and to the renal parenchyma itself. The renal vessels were effectively shaved off the mass and the mass was resected with satisfactory margin. The mass was close to the renal vessels; however, the planes were distinguishable during laparoscopy and tumor was resected with acceptable margins.

CT scan imaging revealed a mass in the left renal hilum that enhanced after injection of the intravenous contrast (A). The lesion did not invade the pyelocalyceal system (B).

CT scan imaging revealed a mass in the left renal hilum that enhanced after injection of the intravenous contrast (A). The lesion did not invade the pyelocalyceal system (B). The pathologic examination was compatible with Castleman disease (Fig. 2). This woman underwent follow-up with no adjunctive therapy. No evidence of recurrence was present in the CT scan imaging at 1-year follow-up.

Pathologic examination of the specimen.

Pathologic examination of the specimen.

Conclusion

Although Castleman disease is relatively rare, it should be one of the differential diagnoses in the management of masses with lymphoid proliferation. Transperitoneal laparoscopic approach is feasible and effective in the management of this disease and is curative.
  5 in total

1.  [Castleman's disease of the kidney: a case report].

Authors:  Yoko Koh; Takanori Kinjo; Daichi Nonomura; Yoshiyuki Yamamoto; Suguru Yoneda; Hironori Nomura; Norihide Tei; Shingo Takada; Kiyomi Matsumiya; Ryo Jokoji; Masahiko Tsujimoto
Journal:  Hinyokika Kiyo       Date:  2014-03

2.  Castleman disease in POEMS syndrome with elevated interleukin-6.

Authors:  C Emile; F Danon; J P Fermand; J P Clauvel
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

3.  The clinical behavior of localized and multicentric Castleman disease.

Authors:  J Herrada; F Cabanillas; L Rice; J Manning; W Pugh
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

4.  Castleman's disease of the urachus.

Authors:  Udo Rudloff; Avrum Jacobson; Nora Morgenstern; Yu Chen; Benjamin R Lee
Journal:  Urology       Date:  2004-08       Impact factor: 2.649

5.  Laparoscopic approach to the management of intraabdominal unicentric Castleman's disease.

Authors:  M D Williams; F A Eissien; J R Salameh; G Ailawadi; J F Sweeney
Journal:  Surg Endosc       Date:  2003-06-19       Impact factor: 4.584

  5 in total
  3 in total

1.  [A palpable right lower abdominal mass].

Authors:  C Paasch; E Gatzky; F Renger; M Steinbach; M Strik
Journal:  Chirurg       Date:  2017-07       Impact factor: 0.955

2.  Case report: Castleman's disease involving the renal sinus resembling renal cell carcinoma.

Authors:  Enlong Zhang; Yuan Li; Ning Lang
Journal:  Front Surg       Date:  2022-09-05

3.  Isolated retroperitoneal Castleman's disease: A case report and literature review.

Authors:  Jhen-Hao Jhan; Ching-Chia Li; Wen-Jeng Wu; Hsiang-Ying Lee
Journal:  Clin Case Rep       Date:  2018-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.